Neuro

Johnson & Johnson Medical Devices Companies Signals Commitment to Stroke Treatment With the Announcement of New Neurovascular Business

NICE, France, September 7, 2017 /PRNewswire/ — Johnson & Johnson Medical Devices Companies* today introduced CERENOVUS,** its new neurovascular business, at the European Society of Minimally Invasive Neurological Therapy (ESMINT) 9th Annual Meeting. CERENOVUS, a name derived from the Latin words for ‘new’ and ‘brain’, will focus on delivering innovative therapies for hemorrhagic […]

Cerebrotech Appoints Neurovascular Veteran Martin Dieck to Executive Chairman

PLEASANTON, Calif.–(BUSINESS WIRE)–Cerebrotech Medical Systems, an innovative medical device company focused on the development of a portable brain bioimpedance monitor, today announced that board member Martin Dieck, an experienced entrepreneur with expertise in developing novel neurovascular solutions, will step up to executive chairman, effectively immediately. “I am thrilled to have […]

InspireMD Shares CGuard EPS Video Testimonials From European Key Opinion Leaders

TEL AVIV, ISRAEL–(Marketwired – August 22, 2017) – InspireMD, Inc. (NYSE American: NSPR) (NYSE MKT: NSPR) (NYSE American: NSPR.WS) (NYSE MKT: NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it has posted video testimonials about its CGuard™ Embolic Prevention System from […]

Canon Virginia, Inc. Collaborates with CVR Medical to Manufacture Intuitive, Next-Generation Stroke Prevention Technology

NEWS PROVIDED BY Canon U.S.A., Inc.  10:18 ET NEWPORT NEWS, Va., Aug. 7, 2017 /PRNewswire/ — After recently extending its full range of services to include medical device contract manufacturing and receiving  ISO 13485 certification, Canon Virginia, Inc. (CVI), a wholly owned subsidiary of Canon U.S.A., Inc., announces an intent to collaborate with CVR Global […]

Pulsar and Neuravi Now Part of J&J’s New Cerenovous Neurovascular Business

Johnson & Johnson rolls Pulsar Vascular, Neuravi into new Cerenovus neurovascular biz JULY 25, 2017 BY BRAD PERRIELLO  – MassDevice Johnson & Johnson (NYSE:JNJ) said yesterday that it’s medical device division is rolling the Pulsar Vascular and Neuravi acquisitions into a new neurovascular business dubbed Cerenovus. The New Brunswick, N.J.-based healthcare giant said the new brand, unveiled at […]

Rapid Medical Snags $9 Million to Advance Commercialization of Stroke Products

YOKNEAM, Israel, July 17, 2017 /PRNewswire/ — Rapid Medical, a company focused on the development of neurovascular interventional devices, announced today that it has completed a Series B financing of $9M to advance the commercialization of the company’s minimally invasive stroke treatment and prevention products, the TIGERTRIEVER Revascularization Device, and the COMANECI, Adjustable Remodeling Mesh. […]

Sensome, Formerly Instent, Raises €4.7 Million To Bring The World’s First Connected Stroke Guidewire To Patients

PARIS–(BUSINESS WIRE)–Sensome, formerly Instent, a company developing a revolutionary micro-sensor technology for smart medical devices out of France’s Ecole polytechnique, announced today that it has completed its €4.7m seed round to bring its first product to clinical trials. Venture capital firm Kurma Diagnostics led a syndicate with the new Paris-Saclay […]

MRI Interventions (MRIC) Announces Record Second Quarter Clearpoint System Procedures, And A 79% Year-Over-Year Revenue Increase

IRVINE, Calif., July 11, 2017 (GLOBE NEWSWIRE) — MRI Interventions, Inc. (OTCQB:MRIC) (the “Company”), today announced preliminary results for its second quarter ended June 30, 2017. Reflecting accelerating utilization and an increasing number of ClearPoint sites, total revenue for the three months ended June 30, 2017 was $2.0 million, compared […]

Cerus Endovascular Receives CE Mark Approval For The Contour Neurovascular System For The Treatment Of Intra-Cranial Aneurysms

FREMONT, Calif. and OXFORD, United Kingdom, July 6, 2017 /PRNewswire/ — Cerus Endovascular Ltd. today announced that it has received CE Mark approval for the commercial sale of its Contour Neurovascular System for the treatment of intra-cranial aneurysms (IAs) across the European Union (EU). The Contour Neurovascular System is a unique, fine mesh braid […]